This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Champs, C.
Right arrow Articles by Nordmann, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Champs, C.
Right arrow Articles by Nordmann, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2002, p. 3031-3034, Vol. 46, No. 9
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.9.3031-3034.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Prospective Survey of ß-Lactamases Produced by Ceftazidime- Resistant Pseudomonas aeruginosa Isolated in a French Hospital in 2000

Christophe De Champs,1* Laurent Poirel,2 Richard Bonnet,1 Danielle Sirot,1 Catherine Chanal,1 Jacques Sirot,1 and Patrice Nordmann2

Service de Bactériologie, Faculté de Médecine, Université d'Auvergne, 63001 Clermont-Ferrand,1 Service de Bactériologie-Virologie, Hôpital de Bicêtre, Assistance Publique/Hôpitaux de Paris, Faculté de Médecine Paris-Sud, 94275 Le Kremlin-Bicêtre, France2

Received 24 October 2001/ Returned for modification 7 February 2002/ Accepted 14 May 2002

In 2000, at the Université d'Auvergne teaching hospital in Clermont-Ferrand, France, 44 (6.2%) strains of Pseudomonas aeruginosa were found to be resistant to ceftazidime. After genotyping, 34 strains were selected. Nine had an additional ß-lactamase: OXA-21 (n = 6), PSE-1 (CARB-2) (n = 2), or PER-1 (n = 1). Ceftazidime resistance was related solely to the overproduction of the cephalosporinase in 30 strains. Sequencing of five blaAmpC genes encoding cephalosporinases with different pIs showed 99% identity with the ampC gene of P. aeruginosa PAO1.


* Corresponding author. Mailing address: Faculté de Médecine, Service de Bactériologie, 28, place Henri Dunant, 63001 Clermont-Ferrand Cedex, France. Phone: 33 4 73 17 81 54. Fax: 33 4 73 27 74 94. E-mail: christophe.dechamps{at}u-clermont1.fr.


Antimicrobial Agents and Chemotherapy, September 2002, p. 3031-3034, Vol. 46, No. 9
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.9.3031-3034.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Dubois, V., Arpin, C., Dupart, V., Scavelli, A., Coulange, L., Andre, C., Fischer, I., Grobost, F., Brochet, J.-P., Lagrange, I., Dutilh, B., Jullin, J., Noury, P., Larribet, G., Quentin, C. (2008). {beta}-Lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). J Antimicrob Chemother 62: 316-323 [Abstract] [Full Text]  
  • Brasme, L., Nordmann, P., Fidel, F., Lartigue, M. F., Bajolet, O., Poirel, L., Forte, D., Vernet-Garnier, V., Madoux, J., Reveil, J. C., Alba-Sauviat, C., Baudinat, I., Bineau, P., Bouquigny-Saison, C., Eloy, C., Lafaurie, C., Simeon, D., Verquin, J. P., Noel, F., Strady, C., De Champs, C. (2007). Incidence of class A extended-spectrum {beta}-lactamases in Champagne-Ardenne (France): a 1 year prospective study. J Antimicrob Chemother 60: 956-964 [Abstract] [Full Text]  
  • Henrichfreise, B., Wiegand, I., Pfister, W., Wiedemann, B. (2007). Resistance Mechanisms of Multiresistant Pseudomonas aeruginosa Strains from Germany and Correlation with Hypermutation. Antimicrob. Agents Chemother. 51: 4062-4070 [Abstract] [Full Text]  
  • Henrichfreise, B., Wiegand, I., Luhmer-Becker, I., Wiedemann, B. (2007). Development of Resistance in Wild-Type and Hypermutable Pseudomonas aeruginosa Strains Exposed to Clinical Pharmacokinetic Profiles of Meropenem and Ceftazidime Simulated In Vitro. Antimicrob. Agents Chemother. 51: 3642-3649 [Abstract] [Full Text]  
  • Empel, J., Filczak, K., Mrowka, A., Hryniewicz, W., Livermore, D. M., Gniadkowski, M. (2007). Outbreak of Pseudomonas aeruginosa Infections with PER-1 Extended-Spectrum {beta}-Lactamase in Warsaw, Poland: Further Evidence for an International Clonal Complex. J. Clin. Microbiol. 45: 2829-2834 [Abstract] [Full Text]  
  • Strateva, T., Ouzounova-Raykova, V., Markova, B., Todorova, A., Marteva-Proevska, Y., Mitov, I. (2007). Problematic clinical isolates of Pseudomonas aeruginosa from the university hospitals in Sofia, Bulgaria: current status of antimicrobial resistance and prevailing resistance mechanisms. J Med Microbiol 56: 956-963 [Abstract] [Full Text]  
  • Papagiannitsis, C. C., Loli, A., Tzouvelekis, L. S., Tzelepi, E., Arlet, G., Miriagou, V. (2007). SCO-1, a Novel Plasmid-Mediated Class A {beta}-Lactamase with Carbenicillinase Characteristics from Escherichia coli. Antimicrob. Agents Chemother. 51: 2185-2188 [Abstract] [Full Text]  
  • Takeda, S., Nakai, T., Wakai, Y., Ikeda, F., Hatano, K. (2007). In Vitro and In Vivo Activities of a New Cephalosporin, FR264205, against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 51: 826-830 [Abstract] [Full Text]  
  • Horianopoulou, M., Legakis, N. J., Kanellopoulou, M., Lambropoulos, S., Tsakris, A., Falagas, M. E. (2006). Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit.. J Med Microbiol 55: 1435-1439 [Abstract] [Full Text]  
  • Naas, T., Aubert, D., Lambert, T., Nordmann, P. (2006). Complex Genetic Structures with Repeated Elements, a sul-Type Class 1 Integron, and the blaVEB Extended-Spectrum {beta}-Lactamase Gene.. Antimicrob. Agents Chemother. 50: 1745-1752 [Abstract] [Full Text]  
  • Hocquet, D., Nordmann, P., El Garch, F., Cabanne, L., Plesiat, P. (2006). Involvement of the MexXY-OprM Efflux System in Emergence of Cefepime Resistance in Clinical Strains of Pseudomonas aeruginosa.. Antimicrob. Agents Chemother. 50: 1347-1351 [Abstract] [Full Text]  
  • Brown, S., Amyes, S. (2006). OXA {beta}-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother 57: 1-3 [Abstract] [Full Text]  
  • Paterson, D. L., Bonomo, R. A. (2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18: 657-686 [Abstract] [Full Text]  
  • Lee, S., Park, Y.-J., Kim, M., Lee, H. K., Han, K., Kang, C. S., Kang, M. W. (2005). Prevalence of Ambler class A and D {beta}-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J Antimicrob Chemother 56: 122-127 [Abstract] [Full Text]  
  • Aubert, D., Girlich, D., Naas, T., Nagarajan, S., Nordmann, P. (2004). Functional and Structural Characterization of the Genetic Environment of an Extended-Spectrum {beta}-Lactamase blaVEB Gene from a Pseudomonas aeruginosa Isolate Obtained in India. Antimicrob. Agents Chemother. 48: 3284-3290 [Abstract] [Full Text]  
  • De Champs, C., Chanal, C., Sirot, D., Baraduc, R., Romaszko, J. P., Bonnet, R., Plaidy, A., Boyer, M., Carroy, E., Gbadamassi, M. C., Laluque, S., Oules, O., Poupart, M. C., Villemain, M., Sirot, J. (2004). Frequency and diversity of Class A extended-spectrum {beta}-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemother 54: 634-639 [Abstract] [Full Text]  
  • Girlich, D., Naas, T., Nordmann, P. (2004). Biochemical Characterization of the Naturally Occurring Oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 48: 2043-2048 [Abstract] [Full Text]  
  • Weldhagen, G. F., Poirel, L., Nordmann, P. (2003). Ambler Class A Extended-Spectrum {beta}-Lactamases in Pseudomonas aeruginosa: Novel Developments and Clinical Impact. Antimicrob. Agents Chemother. 47: 2385-2392 [Full Text]  
  • Poirel, L., Menuteau, O., Agoli, N., Cattoen, C., Nordmann, P. (2003). Outbreak of Extended-Spectrum {beta}-Lactamase VEB-1-Producing Isolates of Acinetobacter baumannii in a French Hospital. J. Clin. Microbiol. 41: 3542-3547 [Abstract] [Full Text]  
  • Mammeri, H., Poirel, L., Mangeney, N., Nordmann, P. (2003). Chromosomal Integration of a Cephalosporinase Gene from Acinetobacter baumannii into Oligella urethralis as a Source of Acquired Resistance to {beta}-Lactams. Antimicrob. Agents Chemother. 47: 1536-1542 [Abstract] [Full Text]